Compare AU

Compare CURE vs. INIF

Compare shares and ETFs on the ASX that you can trade on Pearler.

S&P US Biotech

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are CURE and INIF. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

CURE

INIF

Popularity

Low

Low

Pearlers invested

83

10

Median incremental investment

$619.50

$993.72

Median investment frequency

Monthly

Monthly

Median total investment

$1,437.24

$7,925.42

Average age group

> 35

26 - 35


Key Summary

CURE

INIF

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

INIF.AX was created on 2018-06-18 by Intelligent Investor . The fund's investment portfolio concentrates primarily on total market equity. To achieve a total return of 1% above the S&P/ASX Accumulation Index p.a. and have a distribution yield 2% greater that the Intelligent Investor Growth Fund over rolling five year periods.

Top 3 holdings

Natera Inc (3.33 %)

Incyte Corp (2.95 %)

Gilead Sciences Inc (2.81 %)

Intelligent Investor Aus Equity Income Fund (Managed Fund) (100 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.45 %

0.97 %


Key Summary

CURE

INIF

Issuer

Global X

Intelligent Investor

Tracking index

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.45 %

0.97 %

Price

$51.33

$2.83

Size

$36.301 million

$77.824 million

10Y return

N/A

N/A

Annual distribution/ dividend yield (5Y)

4.24 %

6.27 %

Market

ASX

ASX

First listed date

12/11/2018

19/06/2018

Purchase fee

$6.50

$6.50


Community Stats

CURE

INIF

Popularity

Low

Low

Pearlers invested

83

10

Median incremental investment

$619.50

$993.72

Median investment frequency

Monthly

Monthly

Median total investment

$1,437.24

$7,925.42

Average age group

> 35

26 - 35


Pros and Cons

CURE

INIF

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to US market

  • Higher management fee

CURE

INIF

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home